ARCHIVES

FDA approves Irinotecan, Days After ODAC Meeting

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

AACR Receives Record Number of Abstracts

January 27, 1989

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987